254 related articles for article (PubMed ID: 19258230)
1. [Cognitive impairments and breast cancer: a critical review of the literature].
Vandenbossche S; Fery P; Razavi D
Bull Cancer; 2009 Feb; 96(2):239-48. PubMed ID: 19258230
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
Quesnel C; Savard J; Ivers H
Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
[TBL] [Abstract][Full Text] [Related]
3. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
Schagen SB; Das E; van Dam FS
Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
[TBL] [Abstract][Full Text] [Related]
4. Cognitive adverse effects of chemotherapy in breast cancer patients.
Correa DD; Ahles TA
Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
[TBL] [Abstract][Full Text] [Related]
7. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
[TBL] [Abstract][Full Text] [Related]
8. Renaming "chemobrain".
Hurria A; Somlo G; Ahles T
Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
[TBL] [Abstract][Full Text] [Related]
9. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
[TBL] [Abstract][Full Text] [Related]
10. Cancer, cognitive impairment, and meditation.
Biegler KA; Chaoul MA; Cohen L
Acta Oncol; 2009; 48(1):18-26. PubMed ID: 19031161
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research.
Vardy J; Rourke S; Tannock IF
J Clin Oncol; 2007 Jun; 25(17):2455-63. PubMed ID: 17485710
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive changes in cancer survivors.
Correa DD; Ahles TA
Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer.
Stewart A; Bielajew C; Collins B; Parkinson M; Tomiak E
Clin Neuropsychol; 2006 Feb; 20(1):76-89. PubMed ID: 16410227
[TBL] [Abstract][Full Text] [Related]
14. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
[TBL] [Abstract][Full Text] [Related]
15. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
[TBL] [Abstract][Full Text] [Related]
16. Does endocrine therapy for the treatment and prevention of breast cancer affect memory and cognition?
Jenkins V; Atkins L; Fallowfield L
Eur J Cancer; 2007 Jun; 43(9):1342-7. PubMed ID: 17499988
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer.
Cimprich B; So H; Ronis DL; Trask C
Psychooncology; 2005 Jan; 14(1):70-8. PubMed ID: 15386786
[TBL] [Abstract][Full Text] [Related]
18. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.
Jansen CE; Miaskowski C; Dodd M; Dowling G
Oncol Nurs Forum; 2005 Mar; 32(2):329-42. PubMed ID: 15759070
[TBL] [Abstract][Full Text] [Related]
20. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
Paraska K; Bender CM
Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
